| 1 |
[GO] |
2025―May―08 |
The Integration of Nanotechnology, Artificial Intelligence (AI), Machine Learning (ML) and 3D-Bioprinting Approaches for Personalized COVID-19 Treatment |
Md. Jasim Uddin, Amol D. Gholap, Tahseen Khan, Amrin Yeasin Proma, Sinthia Masud, Yahya E. Choonara, et al. (+3) S. Gowri, Thomas J. Webster, Md. Faiyazuddin |
| 2 |
[GO] |
2024―Dec―25 |
Ultrashort Antiviral Hydrophobic Peptides Targeting Both Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron XBB Variant and Respiratory Syncytial Virus (RSV) |
Alaa F. Nahhas, Alrayan F. Nahhas, Thomas J. Webster |
| 3 |
[GO] |
2024―Dec―25 |
Nanopeptides Stop the Binding Between the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Spike Protein and Angiotensin-Converting Enzyme 2 (ACE 2) Receptor |
Alaa F. Nahhas, Alrayan F. Nahhas, Thomas J. Webster |
| 4 |
[GO] |
2022―Jul―20 |
Inhibiting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants: Targeting the Spike and Envelope Proteins Using Nanomaterial Like Peptides |
Alaa F. Nahhas, Alrayan F. Nahhas, Abdulrahman A. Alshaikh, Thomas J. Webster |
| 5 |
[GO] |
2022―Jul―20 |
Targeting the Conserved Sequence of the Substrate for the Proteinase of Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2) Using Nano-Networks: Efficacy, Stability, and No Cytotoxicity |
Alaa F. Nahhas, Thomas J. Webster |
| 6 |
[GO] |
2020―Sep―24 |
Exosomes: Applications in Respiratory Infectious Diseases and Prospects for Coronavirus Disease 2019 (COVID-19) |
Jia Feng, Ahmed Waqas, Zhihan Zhu, Lukui Chen |
